NEWS
Our Latest News
ARCHIMED Successfully Completes Take-private of Esperion Therapeutics
Esperion Therapeutics is a commercial-stage biopharmaceutical company bringing innovative cardiometabolic and rare/orphan disease therapies to market for patients with unmet medical needs.
ARCHIMED MedTech sells orthopedic implants maker Citieffe to Poly Medicure, a leading global manufacturer of medical devices
November
21,
2025
ARCHIMED Diagnostics closes its acquisition of ARK Diagnostics
October
28,
2025
ARCHIMED’s FIM Medical becomes the leading developer and distributor of European occupational healthcare devices with its purchase of Vistec GmbH
October
23,
2025
ARCHIMED buys Premium Global Dental Healthcare US Company ZimVie
October
20,
2025
368